CompletedNANCT05421715

Preliminary Study for the Evaluation of Teleduc-diab Additional Remote Digitalcare Effects in Adolescents With Poorly Controled Type 1 Diabetes

Sponsor: University Hospital, Toulouse

Trial Details

Conditiontype1diabetes
InterventionTELEDUC-DIAB
PhaseNA
StatusCompleted
Participants10
Est. Completion11 Oct 2024
Last Updated8 May 2026

Primary Outcome

Evolution of glycemic control hemoglobin (HbA1c) between inclusion and 6 months

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Adolescent aged ≥12 and \<18, with primary type 1 diabetes detected for at least 12 months, treated with multi-injection insulin or insulin pump * Glycated hemoglobin greater than or equal to 8% for more than 3 months * Use a continuous interstitial glucose recording system (CGM) * Have at least one parent/guardian with a significant caregiver role in the management of the adolescent's diabetes (as determined by the investigator) participating in the study * Have digital media compatible with the digital applications of the TELEDUC- DIAB (Mobile phone and computer) Exclusion Criteria: • Other pathologies associated with diabetes which, according to the investigator, could interfere with glycemic control or the management of adolescent diabetes (examples: secondary diabetes, cystic fibrosis, Down syndrome; transplants, corticosteroid therapy, etc.)

Trial Sites

Countries

France
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service